The ISPOR 23rd Annual International Meeting in Baltimore, Maryland, on May 19-23 is almost here, and Precision Health Economics (PHE) and Precision Xtract will be there ready to meet with you and share our expertise. (more…)
Precision’s All Access is our bimonthly newsletter with original content written by our payer experts for market access leaders. (more…)
In an article in Pharmaceutical Commerce, Precision’s Dominic Galante and Maureen Hennessey stress the importance of patient support services among pharma companies, payers, and providers. (more…)
In part 2 of their Guest Commentary series, Precision’s Todd Edgar, Alex Grosvenor, and Kellie Rademacher highlight the takeaways of the NOR-SWITCH trial and how the EU’s view of biosimilars as therapeutic alternatives is influencing US policy. (more…)
Register today to stream our recent webinar Defend Your Value: Syncing Evidence and Access Strategies to Prepare for US Value Assessments. (more…)
In a sit-down Q&A with PM360, Jeremy Schafer provides clarity and insight on the potential impact UnitedHealthcare’s new rebate plan will have on pharma. (more…)
Precision’s Ross Maclean and Jeroen Jansen encourage biopharma and medical device industries to embrace the developments around value assessment and to take a leading role in improving the transparency of cost-effectiveness evaluations. (more…)
In a feature in Pharma Live, Precision’s Jeremy Schafer and Maureen Hennessy predict that the projected growth in healthcare spend is creating an inevitable marketplace shift from volume to value. (more…)
Precision’s Jason Shafrin comments in PMLive on the importance of real-world evidence and the benefits of electronic medical records in generating evidence. (more…)
We are very proud to announce that Medical Marketing & Media (MM&M) has named Precision Value & Health President Dan Renick as one of its Top 10 Innovation Catalysts for 2018. (more…)